$EW

Bernard J. Zovighian

Edwards Lifesciences

CEO • Since 2023 • Health Care

📊 CEO Reputation Score

FY2025 vs FY2024 · Source: SEC EDGAR filings

50/100

Blend of this company's year-over-year free-cash-flow and profit improvement, each ranked as a percentile against every scored company in the three indexes.

Free cash flow: $290M → $1.3B (+360.5% YoY) — fiscal 2025 vs fiscal 2024
Profit (net income): $4.2B → $1.1B (−74.3% YoY) — fiscal 2025 vs fiscal 2024

How this score works · S&P 500 reputation leaderboard

Overview

Bernard J. Zovighian is the ceo of Edwards Lifesciences since 2023. Edwards Lifesciences is a Health Care company headquartered in Irvine, California, founded in 1958, and one of the 500 companies in the S&P 500 — every one of which is profiled on this site.

Leadership

Bernard holds the chief executive role at Edwards Lifesciences with the title CEO — in post since 2023. This page is the concise leadership record for Edwards Lifesciences in the S&P 500 CEO index; the site's fully researched long-form profiles (career timelines, education, achievements, setbacks, philosophy and sourced quotes) currently cover the index's ten largest companies, and this entry will be expanded in the same format.

At a Glance

Sector: Health Care
Ticker: $EW
Headquarters: Irvine, California
Founded: 1958
CEO since: 2023
Index: S&P 500 (#164 of 500)